Application of curcumin in preparing medicine for treating IIIV-1 relevant cognitive disorder

A technology for cognitive impairment and HIV-1, which can be used in drug combinations, antiviral agents, pharmaceutical formulations, etc., and can solve problems that have not been seen in research and development.

Inactive Publication Date: 2007-08-22
JINAN UNIVERSITY
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Curcumin is a phenolic pigment extracted from the rhizome of turmeric (curcuma longa), a plant of the genus Zingiberaceae. The research and development of curcumin in HIV-1gp120-induced cognitive impairment has not been seen.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of curcumin in preparing medicine for treating IIIV-1 relevant cognitive disorder
  • Application of curcumin in preparing medicine for treating IIIV-1 relevant cognitive disorder
  • Application of curcumin in preparing medicine for treating IIIV-1 relevant cognitive disorder

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Experimental animals: 90 healthy and clean SD rats, half male and half male, weighing 150-200 grams, divided into 6 groups, namely blank control group, sham operation group, gp120 model group, gp120+curcumin low, medium and high 3 dose groups, 15 rats in each group. Inject gp120 into the lateral ventricle of rats for 3 consecutive days, 50ng / d, to prepare a model of pseudo-HAD learning and memory impairment. The blank control group, the sham operation group and the gp120 model group were gavaged with double distilled water for 2 weeks, and the treatment group was given turmeric Three doses of low (50mg / kg), medium (100mg / kg), and high (200mg / kg) were given orally, once a day, for 2 consecutive weeks. Then:

[0021] 1. The spatial learning ability of rats in each group was detected by Morris water maze.

[0022] 2. Through the brain slice patch clamp technique, the extracellular field potential was recorded, and then the long-term potentiation (LTP) of rats in each gro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides the application of curcumin in preparing medicine for treating HIV-1 relevant cognitive disorder. Curcumin may be used in preparing medicine for treating HIV-1 relevant cognitive disorder alone or through combination with other memory improving medicine. Experiment shows that curcumin can improve the memory capacity of rat with memory disorder caused by HIV-1gp120, with curcumin in low dosage (50 mg / kg) possessing higher effect.

Description

technical field [0001] The raw materials involved in the present invention are traditional Chinese medicines, specifically the use in the preparation of anti-HIV-1 related cognitive impairment Chinese medicine preparations. Background technique [0002] Public health organizations believe that HIV (human immunodeficiency virus) disease is currently the greatest threat to public health. At present, there are about 40 million HIV-infected people in the world, and the number of HIV-infected people in China has reached 1 million, and the number of infected people is increasing by 16,000 every day. In the global AIDS caused by HIV-1, about 30% of adults and 50% of children develop AIDS-associated dementia (HIV-1 associated dementia, HAD) due to the presence of progressive viral infection, that is, cognitive, motor or behavioral impairment. But because some antiretroviral drugs cannot effectively cross the blood-brain barrier and enter the brain parenchyma, although patients can...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/12A61K36/258A61K36/69A61K36/39A61P31/18A61P25/00
Inventor 董军陆大祥潘锐唐红梅
Owner JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products